PERCEPTIVE ADVISORS LLC Q4 2020 Filing
Filed February 16, 2021
Portfolio Value
$9.3B
Holdings
139
Report Date
Q4 2020
Filing Type
13F-HR
All Holdings (139 positions)
| # | Stock | Shares | Value | % Portfolio | Type |
|---|---|---|---|---|---|
| 1 | MRTXEURMIRATI THERAPEUTICS INC | 3,693,516 | $811.2B | 8705.93% | |
| 2 | AM6AMICUS THERAPEUTICS INC | 25,112,048 | $579.8B | 6222.57% | |
| 3 | BBIOBRIDGEBIO PHARMA INC | 6,706,268 | $476.9B | 5117.71% | |
| 4 | TVTX 2.5 09/15/25RETROPHIN INC | 45,000,000 | $442.5B | 4748.95% | |
| 5 | IOVAIOVANCE BIOTHERAPEUTICS INC | 9,166,304 | $425.3B | 4564.32% | |
| 6 | NVTA1EURINVITAE CORP | 7,284,466 | $304.6B | 3268.44% | |
| 7 | SWTXSPRINGWORKS THERAPEUTICS INC | 4,177,721 | $303.0B | 3251.33% | |
| 8 | GBTUSDGLOBAL BLOOD THERAPEUTICS IN | 5,674,711 | $245.8B | 2637.51% | |
| 9 | HZNPHORIZON THERAPEUTICS PUB L | 3,084,042 | $225.6B | 2421.01% | |
| 10 | —ZYMEWORKS INC | 4,300,999 | $203.3B | 2181.36% | |
| 11 | RCKTROCKET PHARMACEUTICALS INC | 3,396,867 | $186.3B | 1999.12% | |
| 12 | NBIXNEUROCRINE BIOSCIENCES INC | 1,899,215 | $182.0B | 1953.58% | |
| 13 | —COLLEGIUM PHARMACEUTICAL INC | 17,500,000 | $173.3B | 1859.25% | |
| 14 | NVROEURNEVRO CORP | 977,565 | $169.2B | 1815.97% | |
| 15 | NVRO 2.75 04/01/25NEVRO CORP | 9,000,000 | $165.4B | 1775.22% | |
| 16 | OMGBPOUTSET MED INC | 2,847,822 | $161.9B | 1737.12% | |
| 17 | VAC2USDVBI VACCINES INC | 55,042,465 | $151.4B | 1624.40% | |
| 18 | ATNXEURATHENEX INC | 13,532,467 | $149.7B | 1606.19% | |
| 19 | AVIRATEA PHARMACEUTICALS INC | 3,109,224 | $129.9B | 1394.07% | |
| 20 | NVV1NOVAVAX INC | 1,043,000 | $116.3B | 1248.14% | |
| 21 | —FREQUENCY THERAPEUTICS INC | 3,259,635 | $114.9B | 1233.43% | |
| 22 | KODKODIAK SCIENCES INC | 751,533 | $110.4B | 1184.85% | |
| 23 | —ATHIRA PHARMA INC | 3,114,805 | $106.7B | 1144.87% | |
| 24 | MGTXMEIRAGTX HLDGS PLC | 6,933,277 | $105.0B | 1126.49% | |
| 25 | CCCCC4 THERAPEUTICS INC | 3,158,566 | $104.6B | 1122.99% | |
| 26 | RLAYRELAY THERAPEUTICS INC | 2,329,407 | $96.8B | 1038.92% | |
| 27 | TVTXTRAVERE THERAPEUTICS INC | 3,493,607 | $95.2B | 1021.84% | |
| 28 | —EIDOS THERAPEUTICS INC | 686,922 | $90.4B | 969.97% | |
| 29 | BDQMALBIREO PHARMA INC | 2,360,139 | $88.5B | 950.06% | |
| 30 | —QUOTIENT LTD | 16,200,818 | $84.4B | 905.81% | |
| 31 | KRON1USDKRONOS BIO INC | 2,780,097 | $83.0B | 891.16% | |
| 32 | ARWRARROWHEAD PHARMACEUTICALS IN | 1,070,814 | $82.2B | 881.75% | |
| 33 | SLDBSOLID BIOSCIENCES INC | 10,803,857 | $81.9B | 878.84% | |
| 34 | CHRSCOHERUS BIOSCIENCES INC | 4,671,836 | $81.2B | 871.37% | |
| 35 | CERE1EURCEREVEL THERAPEUTICS HLDNG I | 4,544,062 | $75.3B | 808.52% | |
| 36 | PRVBUSDPROVENTION BIO INC | 4,224,389 | $71.6B | 767.96% | |
| 37 | —KADMON HLDGS INC | 15,711,334 | $65.2B | 699.72% | |
| 38 | IMVTIMMUNOVANT INC | 1,400,000 | $64.7B | 693.97% | |
| 39 | —ONCORUS INC | 1,989,987 | $64.3B | 690.43% | |
| 40 | NARIUSDINARI MED INC | 668,500 | $58.4B | 626.22% | |
| 41 | ZNTLZENTALIS PHARMACEUTICALS INC | 1,050,003 | $54.5B | 585.27% | |
| 42 | PMVPPMV PHARMACEUTICALS INC | 885,556 | $54.5B | 584.56% | |
| 43 | TARSTARSUS PHARMACEUTICALS INC | 1,296,416 | $53.6B | 575.00% | |
| 44 | ADPTADAPTIVE BIOTECHNOLOGIES COR | 904,854 | $53.5B | 574.18% | |
| 45 | CRNXCRINETICS PHARMACEUTICALS IN | 3,659,381 | $51.6B | 554.11% | |
| 46 | —UROVANT SCIENCES LTD | 3,116,831 | $50.3B | 539.52% | |
| 47 | CMPSCOMPASS PATHWAYS PLC | 1,047,404 | $49.9B | 535.48% | |
| 48 | —AGILE THERAPEUTICS INC | 15,919,925 | $45.7B | 490.33% | |
| 49 | ARNAEURARENA PHARMACEUTICALS INC | 575,007 | $44.2B | 474.10% | |
| 50 | —FORMA THERAPEUTICS HLDGS INC | 1,250,000 | $43.6B | 468.17% | |
| 51 | ALDXALDEYRA THERAPEUTICS INC | 6,285,458 | $43.1B | 462.72% | |
| 52 | STOKSTOKE THERAPEUTICS INC | 671,978 | $41.6B | 446.61% | |
| 53 | COLLCOLLEGIUM PHARMACEUTICAL INC | 2,058,068 | $41.2B | 442.39% | |
| 54 | VRCAVERRICA PHARMACEUTICALS INC | 3,410,412 | $39.3B | 421.26% | |
| 55 | SG7SAGE THERAPEUTICS INC | 440,000 | $38.1B | 408.49% | |
| 56 | LYRALYRA THERAPEUTICS INC | 3,222,561 | $36.7B | 394.25% | |
| 57 | —VYNE THERAPEUTICS INC | 22,876,410 | $36.1B | 387.89% | |
| 58 | COGTCOGENT BIOSCIENCES INC | 3,188,750 | $35.8B | 384.30% | |
| 59 | —NEPTUNE WELLNESS SOLUTIONS I | 22,214,683 | $34.7B | 371.90% | |
| 60 | ADMAADMA BIOLOGICS INC | 16,584,802 | $32.3B | 347.06% | |
| 61 | RNAAVIDITY BIOSCIENCES INC | 1,235,818 | $31.5B | 338.45% | |
| 62 | RAPTEURRAPT THERAPEUTICS INC | 1,577,481 | $31.2B | 334.34% | |
| 63 | OPHTEURIVERIC BIO INC | 4,482,713 | $31.0B | 332.42% | |
| 64 | SILKSILK RD MED INC | 465,100 | $29.3B | 314.35% | |
| 65 | ALLOALLOGENE THERAPEUTICS INC | 1,143,790 | $28.9B | 309.81% | |
| 66 | MGNXMACROGENICS INC | 1,261,060 | $28.8B | 309.37% | |
| 67 | XBISPDR SER TR | 200,000 | $28.2B | 302.16% | Put |
| 68 | VERUEURVERU INC | 3,250,000 | $28.1B | 301.70% | |
| 69 | ACCDEURACCOLADE INC | 626,591 | $27.3B | 292.50% | |
| 70 | CNCEEURCONCERT PHARMACEUTICALS INC | 2,150,641 | $27.2B | 291.73% | |
| 71 | IMTXIMMATICS N.V | 2,500,000 | $27.0B | 289.48% | |
| 72 | REGNREGENERON PHARMACEUTICALS | 55,175 | $26.7B | 286.06% | |
| 73 | LUNGPULMONX CORP | 385,000 | $26.6B | 285.17% | |
| 74 | —FUSION PHARMACEUTICALS INC | 2,235,983 | $26.3B | 281.95% | |
| 75 | ESTAESTABLISHMENT LABS HLDGS INC | 696,633 | $26.2B | 281.39% | |
| 76 | ANABANAPTYSBIO INC | 1,195,336 | $25.7B | 275.80% | |
| 77 | FDMT4D MOLECULAR THERAPEUTICS IN | 600,256 | $24.9B | 267.01% | |
| 78 | —1LIFE HEALTHCARE INC | 519,844 | $22.7B | 243.51% | |
| 79 | NSTGEURNANOSTRING TECHNOLOGIES INC | 337,800 | $22.6B | 242.45% | |
| 80 | PCVXVAXCYTE INC | 850,000 | $22.6B | 242.37% | |
| 81 | GONGERON CORP | 13,461,538 | $21.4B | 229.70% | |
| 82 | —THERAPEUTICS ACQUISITION COR | 1,500,000 | $20.9B | 224.08% | |
| 83 | AMRSEURAMYRIS INC | 3,333,332 | $20.6B | 220.89% | |
| 84 | VRNAVERONA PHARMA PLC | 2,888,889 | $20.2B | 217.01% | |
| 85 | WVEWAVE LIFE SCIENCES LTD | 2,500,000 | $19.7B | 211.14% | |
| 86 | LPTXEURLEAP THERAPEUTICS INC | 8,476,496 | $19.1B | 204.67% | |
| 87 | VTRSVIATRIS INC | 1,004,419 | $18.8B | 202.00% | |
| 88 | RGENREPLIGEN CORP | 97,500 | $18.7B | 200.51% | |
| 89 | SCYXSCYNEXIS INC | 2,400,000 | $18.4B | 197.03% | |
| 90 | HRMYHARMONY BIOSCIENCES HLDGS IN | 502,622 | $18.2B | 194.99% | |
| 91 | NBTXNANOBIOTIX SA | 1,100,000 | $18.1B | 194.78% | |
| 92 | —DICERNA PHARMACEUTICALS INC | 800,000 | $17.6B | 189.13% | |
| 93 | —DBV TECHNOLOGIES S A | 6,595,505 | $17.3B | 185.44% | |
| 94 | CTMXCYTOMX THERAPEUTICS INC | 2,577,043 | $16.9B | 181.15% | |
| 95 | MORFMORPHIC HLDG INC | 487,000 | $16.3B | 175.34% | |
| 96 | —LONGVIEW ACQUISITION CORP | 700,000 | $15.2B | 162.64% | |
| 97 | TARAPROTARA THERAPEUTICS INC | 608,544 | $14.7B | 158.11% | |
| 98 | AMWLAMERICAN WELL CORP | 525,000 | $13.3B | 142.71% | |
| 99 | PPHVANECK VECTORS ETF TR | 200,000 | $13.3B | 142.67% | Put |
| 100 | TOCAEURFORTE BIOSCIENCES INC | 350,000 | $12.7B | 136.76% |
Page 1 of 2Next